Back to Search
KIFFANY PEGGS, MD
MD
Geriatric Medicine (Internal Medicine) Physician
NPI: 1285809947Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
45672(TN)
Geriatric Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Geriatric Medicine
Code: 207RG0300X
45672(TN)
Research & Publications (20)
Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder.
PMID 19234514·Bone Marrow Transplant·2009
5-case
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.
PMID 19659765·Clin Exp Immunol·2009
6-review
Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma.
PMID 19064981·J Clin Oncol·2009
8-other
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.
PMID 19581407·J Exp Med·2009
7-preclinical
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
PMID 18940684·Biol Blood Marrow Transplant·2008
4-observational
High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.
PMID 18158961·Biol Blood Marrow Transplant·2008
8-other
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
PMID 18759925·Immunol Rev·2008
6-review
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation.
PMID 18195684·Bone Marrow Transplant·2008
4-observational
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.
PMID 18725522·J Exp Med·2008
7-preclinical
Current status of allogeneic stem cell transplantation for treatment of hematologic malignancies.
PMID 17637786·Clin Pharmacol Ther·2007
6-review
Targeting immunosupportive cancer therapies: accentuate the positive, eliminate the negative.
PMID 17785201·Cancer Cell·2007
8-other
A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft.
PMID 17487730·Leuk Lymphoma·2007
8-other
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
PMID 17854309·Br J Haematol·2007
3-trial
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
PMID 17162213·Biol Blood Marrow Transplant·2006
8-other
Improving cellular therapies in Epstein - Barr virus-associated Hodgkin's lymphoma: shifting the equilibrium between effectors and regulators.
PMID 16753861·Leuk Lymphoma·2006
6-review
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
PMID 16778987·J Clin Invest·2006
7-preclinical
Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans.
PMID 17050247·Cytotherapy·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5606 Cloverland Dr Apt 110
Brentwood, TN 37027 - Phone
- (615) 322-4916
Quick Facts
- NPI
- 1285809947
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile